羚锐制药：2025年上半年净利润同比增长14.85%

Group 1 - The company reported a revenue of 2.099 billion yuan for the first half of 2025, representing a year-on-year growth of 10.14% [1] - The net profit for the same period was 474 million yuan, showing a year-on-year increase of 14.85% [1] - The basic earnings per share reached 0.836 yuan, which is a year-on-year growth of 14.21% [1]